Nathan D Wong (Nathan Wong)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 24

Top Topics

Randomized Controlled Trial

Glycemic Control

Acute Heart Failure

Cardiovascular Disease

Top Venues

Cardiovascular drugs and therapy

Diabetes & vascular disease research

Clinical cardiology

This page only lists publications with an associated author ORCID identifier.

Publications

Nathan D Wong, Hridhay Karthikeyan, Wenjun Fan
US Population Eligibility and Estimated Impact of Tirzepatide Treatment on Obesity Prevalence and Cardiovascular Disease Events. Cardiovascular drugs and therapy (2024)
Ned Premyodhin, Wenjun Fan, Millie Arora, Matthew J Budoff, Alka M Kanaya, Namratha Kandula, Latha Palaniappan, Jamal S Rana, Masood Younus, Nathan D Wong
Association of diabetes with coronary artery calcium in South Asian adults and other race/ethnic groups: The multi-ethnic study of atherosclerosis and the mediators of atherosclerosis in South Asians living in America study. Diabetes & vascular disease research 20 (5) (2023)
Nathan D Wong, Hridhay Karthikeyan, Wenjun Fan
US Population Eligibility and Estimated Impact of Semaglutide Treatment on Obesity Prevalence and Cardiovascular Disease Events. Cardiovascular drugs and therapy (2023)
Alexander C Razavi, Cherry Kim, Marly van Assen, Carlo N De Cecco, Daniel S Berman, Matthew J Budoff, Arshed A Quyyumi, Viola Vaccarino, Michael D Miedema, Khurram Nasir, Alan Rozanski, Camilo Fernandez, John A Rumberger, Leslee J Shaw, Martin Bødtker Mortensen, Nathan D Wong, Roger Scott Blumenthal, Laurence S Sperling, Seamus P Whelton, Michael J Blaha, Omar Dzaye
Thoracic Aortic Calcium Density and Area in Long-Term Atherosclerotic Cardiovascular Disease Risk Among Men Versus Women. Circulation. Cardiovascular imaging (2023)
Nathan D Wong, Naveed Sattar
Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nature reviews. Cardiology (2023)
LaPrincess C Brewer, Helayna Abraham, Donald Clark Iii, Melvin R Echols, Michael E Hall, Karen Hodgman, Brian Kaihoi, Stephen L Kopecky, Ashton Krogman, Shawn Leth, Shaista Malik, Jill A Marsteller, Lena Mathews, Robert Scales, Phillip J Schulte, Adam Shultz, Bryan Taylor, Randal J Thomas, Nathan D Wong, Thomas P Olson
Efficacy and Adherence Rates of a Novel Community-Informed Virtual World-Based Cardiac Rehabilitation Program: Protocol for the Destination Cardiac Rehab Randomized Controlled Trial. Journal of the American Heart Association (2023)
Nathan D Wong
Evolution of Coronary Calcium Screening for Assessment of Atherosclerotic Cardiovascular Disease Risk and Role in Preventive Cardiology. Current atherosclerosis reports (2022)
Nathan D Wong
Cardiodiabetology: newer pharmacologic strategies for reducing cardiovascular disease risks. Canadian journal of physiology and pharmacology 100 (10) (2022)
María Eugenia Ramos, Monica Andreis, Craig Beam, Ronnie Bissessar, Deborah Chen, Marielba Cordido, Javier Valenzuela, Andreas Wielgosz, Nathan D Wong
Equity and Prevention of Cardiovascular Diseases in Latin America and the Caribbean. Global heart 17 (1) (2022)
Alka M Kanaya, Ann W Hsing, Sela V Panapasa, Namratha R Kandula, Maria Rosario G Araneta, Daichi Shimbo, Paul J Wang, Scarlett L Gomez, Jinkook Lee, K M Venkat Narayan, Marjorie K Leimomi Mala Mau, Sonali Bose, Martha L Daviglus, Frank B Hu, Nadia Islam, Chandra L Jackson, Merle R Kataoka-Yahiro, John S K Kauwe, Simin Liu, Grace X Ma, Tung T Nguyen, Latha P Palaniappan, V Wendy Setiawan, Chau Trinh-Shevrin, Janice Y Tsoh, R Dhananjay Vaidya, Barbara Vickrey, Thomas J Wang, Nathan D Wong, Sean Coady, Yuling Hong
Knowledge Gaps, Challenges, and Opportunities in Health and Prevention Research for Asian Americans, Native Hawaiians, and Pacific Islanders: A Report From the 2021 National Institutes of Health Workshop. Annals of internal medicine 175 (4) (2022)
Divya Devineni, Meleeka Akbarpour, Yufan Gong, Nathan D Wong
Inadequate Use of Newer Treatments and Glycemic Control by Cardiovascular Risk and Sociodemographic Groups in US Adults with Diabetes in the NIH Precision Medicine Initiative All of Us Research Program. Cardiovascular drugs and therapy (2022)
Yanglu Zhao, Shaista Malik, Matthew J Budoff, Adolfo Correa, Kellan E Ashley, Elizabeth Selvin, Karol E Watson, Nathan D Wong
Identification and Predictors for Cardiovascular Disease Risk Equivalents among Adults With Diabetes Mellitus. Diabetes care (2021)
Wenjun Fan, Corey Tong, Nathan D Wong
LEADER Trial Eligibility and Preventable Cardiovascular Events in US Adults with Diabetes: the National Health and Nutrition Examination Surveys 2007-2016. Cardiovascular drugs and therapy 34 (6) (2020)
Suzanne V Arnold, Kensey Gosch, Nathan D Wong, Vittal Hejjaji, Abhinav Goyal, Lawrence A Leiter, Mikhail Kosiborod
Use of non-LDL-C lipid-lowering medications in patients with type 2 diabetes. Endocrinology, diabetes & metabolism 3 (3) (2020)
Nathan D Wong, Wenjun Fan, Jonathan Pak
Estimating the number of preventable cardiovascular disease events in the United States using the EMPA-REG OUTCOME trial results and National Health and Nutrition Examination Survey. Diabetes & vascular disease research 17 (4) (2020)
Nathan D Wong, Amber R Cordola Hsu, Alan Rozanski, Leslee J Shaw, Seamus P Whelton, Matthew J Budoff, Khurram Nasir, Michael D Miedema, John Rumberger, Michael J Blaha, Daniel S Berman
Sex Differences in Coronary Artery Calcium and Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in Adults With Diabetes: The Coronary Calcium Consortium. Diabetes care 43 (10) (2020)
Eric T Wittbrodt, Narinder Bhalla, Karolina Andersson Sundell, Qi Gao, Liyan Dong, Matthew A Cavender, Phillip R Hunt, Nathan D Wong, Carl Mellström
Assessment of the high risk and unmet need in patients with CAD and type 2 diabetes (ATHENA): US healthcare resource utilization, cost and burden of illness in the Diabetes Collaborative Registry. Endocrinology, diabetes & metabolism 3 (3) (2020)
Nathan D Wong, Ezra A Amsterdam, Christie Ballantyne, Amit Khera, Khurram Nasir, Peter P Toth, null null
Spotlight from the American Society for Preventive Cardiology on Key Features of the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol. American journal of cardiovascular drugs : drugs, devices, and other interventions 20 (1) (2020)
Njambi Mathenge, Wenjun Fan, Nathan D Wong, Calvin Hirsch, Chris Joseph Delaney, Ezra A Amsterdam, Bruce Koch, Rico Calara, Julius M Gardin
Pre-diabetes, diabetes and predictors of incident angina among older women and men in the Cardiovascular Health Study. Diabetes & vascular disease research 17 (1) (2019)
Wenjun Fan, Yang Song, Silvio E Inzucchi, Laurence Sperling, Christopher P Cannon, Suzanne V Arnold, Mikhail Naum Kosiborod, Nathan D Wong
Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: The Diabetes Collaborative Registry. Diabetes, obesity & metabolism 21 (5) (2019)
Wenjun Fan, Sephy Philip, Craig Granowitz, Peter P Toth, Nathan D Wong
Residual Hypertriglyceridemia and Estimated Atherosclerotic Cardiovascular Disease Risk by Statin Use in U.S. Adults With Diabetes: National Health and Nutrition Examination Survey 2007-2014. Diabetes care 42 (12) (2019)
Peter P Toth, Sergio Fazio, Nathan D Wong, Michael Hull, Gregory A Nichols
Risk of cardiovascular events in patients with hypertriglyceridaemia: A review of real-world evidence. Diabetes, obesity & metabolism 22 (3) (2019)
Jay Khambhati, Marc Allard-Ratick, Devinder Dhindsa, Suegene K Lee, John Chen, Pratik B Sandesara, Wesley T O'Neal, Arshed A Quyyumi, Nathan D Wong, Roger S Blumenthal, Laurence S Sperling
Re: The art of cardiovascular risk assessment. Clinical Cardiology 2018;41(5):677-684. Clinical cardiology 41 (8) (2018)
Hwa Mu Lee, Yanglu Zhao, Michael A Liu, David Yanez, Mercedes Carnethon, R Graham Barr, Nathan D Wong
Impact of lung-function measures on cardiovascular disease events in older adults with metabolic syndrome and diabetes. Clinical cardiology 41 (7) (2018)